In order to correlate WDR5 expression and the metastatic process, by using a second independent data set [31], we evaluated WDR5 expression and metastasis-free survival (MFS) association in a cohort of BC patients (n = 295; WDR5 high expression = 148; WDR5 low expression = 147). This evidence concerns the gene WDR5 and breast cancer.